Top Tweets for #InnovEnt
#InnoVent #LinkedInLive – Join experts from #TataTechnologies, @NIglobal, and @AWSCloudIndia to explore innovation opportunities across Automotive, Aerospace, and IHM.
📅 25 June | ⏰ 5:30 PM IST
📍 Location: LinkedIn Live – https://t.co/K7mVL9B1XU

Lorsque les #jeunes apprennent davantage à #réfléchir, à #questionner, à #créer qu’à simplement mémoriser, les résultats deviennent admirables.
Ils ne se contentent plus de reproduire des réponses : ils développent leur #esprit #critique, #innovent et deviennent capables de #transformer leur #environnement.
L’éducation ne devrait pas seulement remplir les esprits, mais aussi allumer des intelligences capables d’#imaginer le #monde de #demain.
Travaillons-y✊🏽🔥

#Hackathon – Can your idea make mobility smarter, faster, safer, and more intelligent at the edge?
#TataTechnologies, in collaboration with @NIglobal and @AWSCloudIndia, is excited to launch the 4th edition of the #InnoVent hackathon, focused on AI at the Edge for Automotive, Industrial Heavy Machinery, and Aerospace.
This is a unique opportunity for 3rd and 4th-year #EngineeringStudents across India to ideate, iterate, and innovate solutions to real-world industry challenges, helping shape the future of intelligent products, smarter machines, and connected systems.
💡 Why participate?
✅ Win cash prizes worth ₹4.5 Lakhs for top-performing teams
✅ Secure direct job opportunities with Tata Technologies for Demo Day finalists
✅ Gain exclusive training and mentorship from subject matter experts at Tata Technologies, Emerson NI, and AWS
✅ Compete for Special Recognitions, including Breakthrough Idea and Social Media Awards
✅ Showcase your innovation to industry leaders
👉 Watch the video to explore project categories, key timelines, and participation details. Learn more at the InnoVent website – https://t.co/mUwchxQSLX
🗓 Submissions close on 5th July 2026
📄 Read the InnoVent-27 launch media release here – https://t.co/8sDsxGxPAW
💬 Tag your team and follow us for behind-the-scenes updates, tips, and highlights.
#EngineeringABetterWorld #InnoVent2027 #StudentHackathon #Innovation
#Innovent Announces Strategic Collaboration with $LLY to Develop New Medicines Globally in Oncology and Immunology https://t.co/7Hu3eQPVbv
#InnoVent2026 – Raw talent meets real-world challenges!
At #TataTechnologies, we believe the right mentorship can turn ambition into impact. Through #InnoVent, we empowered our finalists to craft innovative #SmartMobility solutions that address some of the industry’s most pressing challenges.
📅 Join us LIVE on 22nd January at 6:30 PM IST as we unveil the winners and celebrate their breakthrough ideas.
👉 Register now: https://t.co/4NekB6aGK7
#EngineeringABetterWorld #Mentorship #FutureOfMobility #Hackathon
#InnoVent 2026 Demo Day is approaching! Join us LIVE at the finale to witness the future of #SmartMobility -https://t.co/IkMxoxD5d2
🎥 Witness India's brightest engineering minds showcase their breakthrough prototypes to solve the mobility industry's most critical challenges.
🎤 Meet our jury panel: A stellar lineup of industry veterans, tech pioneers, and academic leaders is set to evaluate these high-impact solutions, share industry-shaping insights, and identify the next generation of engineering talent.
💬 Tell us in the comments: Which technology do you believe will drive the biggest shift in smart mobility — Agentic AI or Software-Defined Vehicles?
Follow #TataTechnologies for live updates, behind-the-scenes moments, and the big winner announcement.
#EngineeringABetterWorld #AWS #FutureOfMobility #Hackathon

#InnoVent – What does the moment of victory look like after months of relentless innovation? 🏆
Throwing it back to that unforgettable moment from our InnoVent 2024 finale, where Team Code Zephyr was crowned champion. Their journey, from a simple concept to a winning solution, embodies the spirit of innovation we champion at Tata Technologies and our vision of #EngineeringABetterWorld.
The bar was set high by teams like CodeZephyr, and now we’re eagerly watching to see who will rise to the challenge next. The wait is almost over! Keep an eye out for the InnoVent 2026 Stage 2 results, which we'll be announcing very soon.
What innovation from a past InnoVent still inspires you today? Drop it in the comments! 👇
#TataTechnologies #Innovation #Champions #Winners #Throwback #DemoDay #Engineering
#InnoVent – What does it look like when months of innovation come down to one single moment on stage? 💡
Throwing it back to the electric atmosphere of the InnoVent 2024 Demo Day! Here’s Team Binary, commanding the stage and presenting their groundbreaking solution with passion and precision.
As we relive the incredible energy of our past innovators, we’re getting ready to discover the next. The future is just around the corner... stay tuned for the InnoVent 2026 Stage 2 results announcement, coming soon!
Let us know your favorite InnoVent memory in the comments below! 👇
#TataTechnologies #Engineering #InnoVent2024 #InnoVent2026
🇨🇳 #Innovent Biologics' dual glucagon/GLP-1 receptor agonist #mazdutide, has been approved for a new indication for marketing, for glycemic control in adult patients with type 2 diabetes.
Previously, the drug has been approved for long-term weight management in adult patients with obesity or overweight. https://t.co/j40byVUebs
Innovent licensed mazdutide from Eli Lilly.
🇨🇳 #Innovent Biologics announced Friday that #mazdutide, a dual #glucagon/GLP-1 receptor agonist licensed from $LLY in 2019, was approved by Chinese #NMPA for chronic weight management in adults with overweight or obesity. https://t.co/BsccMiRmwo
The decision was based on data from the Chinese Phase III GLORY-1 trial, which were presented #ADA2024 https://t.co/f3hfZ6Ylse At week 32, those taking the high dose saw placebo-adjusted weight loss of 13%, which increased to 14.3% at week 48.
Mazdutide is under NMPA review for type 2 diabetes
In DREAMS-2, the high dose of mazdutide lowered HbA1c by 1.73% from baseline at 28 weeks, versus 1.36% for Trulicity. https://t.co/83O5Pr4f7Z

🇨🇳 #Innovent announced that the results of the Phase 2 clinical study of the xanthine oxidase inhibitor (#XOI) tigulixostat (IBI128) in Chinese #gout participants were presented at #aplar25. https://t.co/LX99A6Q4YU
Tigulixostat demonstrated significantly greater urate-lowering efficacy and favorable safety profiles compared to febuxostat across all dose groups. Based on these positive data, Innovent plans to initiate the Phase 3 clinical study of tigulixostat in China in the second half of 2025.
At week 16, 55.0% of participants in the tigulixostat 50 mg group, 81.0% in the tigulixostat 100 mg group, and 85.7% in the tigulixostat 200 mg group, achieved sUA <360 μmol/L (6 mg/dL), respectively, compared with 18.2% in the febuxostat 40 mg group, the treatment difference versus febuxostat was 36.8% (95%CI: 9.7, 63.9, P<0.01), 62.8% (39.5, 86.0, P<0.001), and 67.5% (45.5, 89.5, P<0.001) for the tigulixostat 50 mg group, 100 mg group, and 200 mg group, respectively;

🇨🇳 #Innovent Biologics' U.S. subsidiary, Fortvita Biologics, has registered a Phase 1 clinical trial for the small-molecule GLP-1 receptor agonist #IBI3032 、 https://t.co/SL71xXprpZ.
The Phase 1 trial plans to enroll 32 healthy participants, divided into 4 cohorts, with each cohort consisting of 8 participants receiving IBI3032 or placebo in a 6:2.
According to information disclosed by Innovent at this year's JPM, IBI3032 is an oral small-molecule GLP-1 receptor agonist.

#InnoVent2026 - From 2800+ bold project submissions, emerge the innovative few that move to the next stage of #InnoVent 2026! 🎉🎉
👏 A huge round of applause to the 31 brilliant teams that have made it to the next stage of Tata Technologies #InnoVent 2026!
After 300+ hours of intense evaluation, our expert jury handpicked the brightest innovators in SDV, AI, mobility, sustainability, Industry 4.0, and green tech - ready to shape the future of product development.
These shortlisted innovators now unlock:
🔹Exclusive access to AWS-powered tech infrastructure to scale projects
🔹Exclusive access to Tata Technologies innovation training program
🔹 Hands-on tools & techniques honed by Tata Technologies engineers
🔹 Mentorship from SMEs at Tata Technologies and @AWSCloudIndia
📜 Details of all the shortlisted teams are available here - https://t.co/bw6JSWcpwQ
🎉 Did your project make it? Celebrate with your team, tag your crew, and share the news!
The journey’s just beginning, and we’re here to mentor, scale, and power these innovators to the next stage.
💬 Drop a comment to cheer your favourite team or share what innovation means to you.
👥 Follow Tata Technologies and stay tuned for continuous updates on Tata Technologies #InnoVent 2026!
#TataTechnologies #Hackathon #EngineeringABetterWorld #EngineeringASoftwareDefinedFuture #GenAI #SDV #AI #ML #Mobility #HackTheFuture

🇨🇳 #Innovent Receives FDA Approval for #IND Application of Oral GLP-1R Agonist #IBI3032 https://t.co/0j40qFIO99 #GLP1
The Phase 1 clinical trials of IBI3032 are planned to be conducted concurrently in China and the U.S. Dosing in healthy volunteers and overweight or obese participants is expected to begin in the second half of 2025.
🇨🇳 #NMPA CDE website, #Innovent Biologics' PD-1/IL-2α-bias bispecific antibody therapy #IBI363 has received clearance for two clinical trial applications.
1, as neoadjuvant therapy for non-squamous non-small cell lung cancer
2, IBI363 + bevacizumab, for advanced solid tumor (EGFR+ advanced NSCLC, platinum-resistant ovarian cancer).
ASCO2025, IBI363 was featured in three oral presentations covering colorectal cancer, melanoma, and NSCLC. https://t.co/3qMdmE9a9J
Previously, Innovent’s PD-1 monoclonal antibody sintilimab + bevacizumab had already been approved in China for the treatment of locally advanced or metastatic non-squamous NSCLC with EGFR mutations after failure of EGFR-TKI therapy.
🇨🇳 #ASCO25 #Innovent updated ph1 data of PD-1/IL-2α-bias bispecific antibody #IBI363 in NSCLC https://t.co/LI3eeJ0KMh
more encouraging efficacy signals were observed in the 3 mg/kg group: ORR 43.3% vs 25.9%, confirmed ORR 36.7% vs 25.9%, DCR 90.0% vs 66.7%, median PFS 7.3 (95% CI: 6.0-11.7) vs 5.5 (95% CI: 1.5-8.3) months, with a median follow up time of 7.3 vs 11.1 months.
A higher ORR of 29% versus 4% and a longer PFS of 5.3 months compared to 2.7 months were observed in smokers (N=31, 56.4%).

#Innovent2026 - The⏳ The countdown is ON. Will your idea make the cut?
Only 2 days left to submit your innovation for Tata Technologies #InnoVent 2026—where bold student ideas meet real-world impact.
This is your final boarding call to be part of something bigger—to help us in #EngineeringASoftwareDefinedFuture. Join a vibrant community of innovators, with over 1100+ projects already submitted from 250+ colleges!
Tata Technologies is looking for the next generation of talent ready to #EngineeringABetterWorld. If you have an idea for the future of smart mobility, this is your platform to make a real-world impact.
Submit your project NOW before the portal closes: https://t.co/mUwchxQkWp
Tag your team. Tag your college. Let’s innovate together.
#InnoVent #TataTechnologies #AWS #Hackathon #SmartMobility #Innovation #LastChance #2DaysToGo

#Innovent2026 - Are you ready to solve the real-world challenges powering smart mobility? Showcase your ingenuity at the Tata Technologies #InnoVent Hackathon!
Take inspiration from Aashi Sharma, winner of #Innovent2024. She was part of Team HaxS, which innovated DefectVisionAI, a system designed to transform manufacturing quality control. It leverages advanced AI to instantly find defects like dents and scratches from a live camera feed, tackling the critical need for an automated, highly accurate inspection solution.
Tata Technologies believes that to engineer a better world, we must first engineer better careers — by giving youth the platform to upskill, innovate, and co-create solutions that matter.
👉 Now it’s your turn. Bring your breakthrough idea to #Innovent2026 and help revolutionise the future of the industry. Submit your project by 30th July 2025 here - https://t.co/mUwchxQkWp
👇 Tag a teammate or share with someone who needs to see this.
🔔 Follow Tata Technologies for more real stories of innovation, impact, and future-ready talent.
#EngineeringABetterWorld #EngineeringASoftwareDefinedFuture #Innovation #TataTechnologies #Hackathon #AI #Manufacturing #FutureOfIndustry
#InnoVent – Do you have the vision to design a vehicle that can think, decide, and evolve in real-time?
#InnoVent2026 is here—and it's your official invitation to join us in engineering the future of smart mobility. In an inspiring message, our @santoshsingh1 invites every bold student, future engineer, and mobility dreamer to step up and shine at #InnoVent2026—Tata Technologies’ biggest innovation challenge yet.
From our iconic Emo EV to the award-winning convertible 3-wheeler, we’ve always pushed the boundaries of what’s possible. Now, in partnership with @AWSCloudIndia, we’re handing the wheel to you. Use technologies like AI, Gen AI, Agentic AI, digital twins, and generative design to craft a vehicle that thinks, learns, and evolves.
👉 Submit your future-shaping innovation by 30th July 2025: https://t.co/mUwchxQSLX
💬 Got an idea or a team? Tag them below and start your journey.
🔁 Share this to inspire the next wave of mobility innovators.
🔔 Follow Tata Technologies for more stories of engineering a smarter, sustainable world.
#TataTechnologies #EngineeringABetterWorld #EngineeringASoftwareDefinedFuture #SmartMobility #Innovation #Hackathon #AgenticAI #AWS #StudentInnovation #FutureOfMobility
🇨🇳 #Innovent Biologics has registered a Phase III clinical trial for its novel Claudin18.2-targeting ADC drug, #IBI343, for the treatment of pancreatic cancer https://t.co/SXAWsOi1gQ. The trial, titled G-HOPE-002, plans to enroll 201 patients with advanced pancreatic cancer.
IBI343 features a differentiated design. The ADC technology originates from a collaboration with Synaffix and utilizes glycan-mediated site-specific conjugation, with a drug-to-antibody ratio (DAR) of 4. It employs a highly internalizing antibody and incorporates Fc silencing mutations.
In July, Innovent officially disclosed the molecular structure of IBI343 (Arcotatug tavatecan).
https://t.co/70ncr3Vwvv

#Innovent – Do you have a bold idea that could redefine the future of smart mobility?
#InnoVent2026 is here — and it’s calling on innovators, dreamers, and problem-solvers to think beyond boundaries. In an inspiring message, our Shailesh Saraph urges every participant to challenge convention, embrace AI, electrification, cloud-native platforms, and user-first design, and bring forward ideas that could shape tomorrow’s mobility landscape.
👉 Submit your future-shaping innovation by 30th July 2025: https://t.co/QXr5PVWWB5
💬 Got an idea or a team? Tag them below and start your journey.
🔁 Share this to inspire the next wave of mobility innovators.
🔔 Follow Tata Technologies for more stories of engineering a smarter, sustainable world.
Bonus Knowledge Drop! Did you know our exclusive #LinkedIn newsletter - The India Advantage, unlocks the latest trends, insights, and India's innovation potential, including #AI? Discover our latest edition focused on AI here - https://t.co/i0jXYckkLC
#TataTechnologies #EngineeringABetterWorld #EngineeringASoftwareDefinedFuture #SmartMobility #Innovation #Hackathon #AI #Cloud #Electrification #YouthEmpowerment
Last Seen Hashtags on Sotwe
nolimit(***) filter:native_video
Seen from Brazil
caughtintheact
Seen from United States
Thailand
Seen from United States
teresalavae
Seen from South Africa
pmv() +filter:native_video
Seen from Sweden
คลิปหลุดโป๊
Seen from Thailand
momson() +filter:media()
Seen from Singapore
danyancat
Seen from Argentina
อุทุมพรนัดเยด
Seen from Thailand
monogatari
Seen from Indonesia
Most Popular Users

Elon Musk 
@elonmusk
240.3M followers

Barack Obama 
@barackobama
119.3M followers

Donald J. Trump 
@realdonaldtrump
111.6M followers

Cristiano Ronaldo 
@cristiano
109.8M followers

Narendra Modi 
@narendramodi
106.9M followers

Rihanna 
@rihanna
97.5M followers

NASA 
@nasa
92.1M followers

Justin Bieber 
@justinbieber
90.7M followers

KATY PERRY 
@katyperry
87.3M followers

Taylor Swift 
@taylorswift13
81.1M followers

Lady Gaga 
@ladygaga
72.6M followers

Kim Kardashian 
@kimkardashian
69.6M followers

Virat Kohli 
@imvkohli
69.3M followers

YouTube 
@youtube
68.6M followers

Bill Gates 
@billgates
63.6M followers

The Ellen Show
@theellenshow
62.5M followers

Neymar Jr 
@neymarjr
61.9M followers

CNN 
@cnn
61.9M followers

X 
@x
60.9M followers

Selena Gomez 
@selenagomez
60.4M followers








